Hypersomnia Drug Market, Global Outlook and Forecast 2022-2028

April 2022 | 60 pages | ID: H83C4B3CA0CCEN
Market Monitor Global

Abstracts

Hypersomnia indicates frequent and excessive daytime sleepiness. It becomes necessary for patients suffering from hypersomnia to take short naps in-between the day time and sleep more than 10 hours at night. However, the naps do not provide any relief. Also, patients may feel disoriented and can have difficulty in moving. Due to hypersomnia patients may have restlessness, loss of appetite hallucinations and slow speech.

This report contains market size and forecasts of Hypersomnia Drug in Global, including the following market information:

Global Hypersomnia Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Hypersomnia Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Provigil Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Hypersomnia Drug include Teva, Jazz Pharmaceuticals, BIOPROJET, AVADEL PHARMACEUTICALS, GlaxoSmithKline, Pfizer, Theranexus, Fisher & Paykel Healthcare and Drive Medical and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hypersomnia Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Hypersomnia Drug Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Hypersomnia Drug Market Segment Percentages, by Type, 2021 (%)

• Provigil
• Xyrem
• Others

Global Hypersomnia Drug Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Hypersomnia Drug Market Segment Percentages, by Application, 2021 (%)

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Global Hypersomnia Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Hypersomnia Drug Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Hypersomnia Drug revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Hypersomnia Drug revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Teva
• Jazz Pharmaceuticals
• BIOPROJET
• AVADEL PHARMACEUTICALS
• GlaxoSmithKline
• Pfizer
• Theranexus
• Fisher & Paykel Healthcare
• Drive Medical
• Merck

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Hypersomnia Drug Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Hypersomnia Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL HYPERSOMNIA DRUG OVERALL MARKET SIZE

2.1 Global Hypersomnia Drug Market Size: 2021 VS 2028
2.2 Global Hypersomnia Drug Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Hypersomnia Drug Players in Global Market
3.2 Top Global Hypersomnia Drug Companies Ranked by Revenue
3.3 Global Hypersomnia Drug Revenue by Companies
3.4 Top 3 and Top 5 Hypersomnia Drug Companies in Global Market, by Revenue in 2021
3.5 Global Companies Hypersomnia Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hypersomnia Drug Players in Global Market
  3.6.1 List of Global Tier 1 Hypersomnia Drug Companies
  3.6.2 List of Global Tier 2 and Tier 3 Hypersomnia Drug Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Hypersomnia Drug Market Size Markets, 2021 & 2028
  4.1.2 Provigil
  4.1.3 Xyrem
  4.1.4 Others
4.2 By Type - Global Hypersomnia Drug Revenue & Forecasts
  4.2.1 By Type - Global Hypersomnia Drug Revenue, 2017-2022
  4.2.2 By Type - Global Hypersomnia Drug Revenue, 2023-2028
  4.2.3 By Type - Global Hypersomnia Drug Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Hypersomnia Drug Market Size, 2021 & 2028
  5.1.2 Hospital Pharmacies
  5.1.3 Retail Pharmacies
  5.1.4 Online Pharmacies
5.2 By Application - Global Hypersomnia Drug Revenue & Forecasts
  5.2.1 By Application - Global Hypersomnia Drug Revenue, 2017-2022
  5.2.2 By Application - Global Hypersomnia Drug Revenue, 2023-2028
  5.2.3 By Application - Global Hypersomnia Drug Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Hypersomnia Drug Market Size, 2021 & 2028
6.2 By Region - Global Hypersomnia Drug Revenue & Forecasts
  6.2.1 By Region - Global Hypersomnia Drug Revenue, 2017-2022
  6.2.2 By Region - Global Hypersomnia Drug Revenue, 2023-2028
  6.2.3 By Region - Global Hypersomnia Drug Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Hypersomnia Drug Revenue, 2017-2028
  6.3.2 US Hypersomnia Drug Market Size, 2017-2028
  6.3.3 Canada Hypersomnia Drug Market Size, 2017-2028
  6.3.4 Mexico Hypersomnia Drug Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Hypersomnia Drug Revenue, 2017-2028
  6.4.2 Germany Hypersomnia Drug Market Size, 2017-2028
  6.4.3 France Hypersomnia Drug Market Size, 2017-2028
  6.4.4 U.K. Hypersomnia Drug Market Size, 2017-2028
  6.4.5 Italy Hypersomnia Drug Market Size, 2017-2028
  6.4.6 Russia Hypersomnia Drug Market Size, 2017-2028
  6.4.7 Nordic Countries Hypersomnia Drug Market Size, 2017-2028
  6.4.8 Benelux Hypersomnia Drug Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Hypersomnia Drug Revenue, 2017-2028
  6.5.2 China Hypersomnia Drug Market Size, 2017-2028
  6.5.3 Japan Hypersomnia Drug Market Size, 2017-2028
  6.5.4 South Korea Hypersomnia Drug Market Size, 2017-2028
  6.5.5 Southeast Asia Hypersomnia Drug Market Size, 2017-2028
  6.5.6 India Hypersomnia Drug Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Hypersomnia Drug Revenue, 2017-2028
  6.6.2 Brazil Hypersomnia Drug Market Size, 2017-2028
  6.6.3 Argentina Hypersomnia Drug Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Hypersomnia Drug Revenue, 2017-2028
  6.7.2 Turkey Hypersomnia Drug Market Size, 2017-2028
  6.7.3 Israel Hypersomnia Drug Market Size, 2017-2028
  6.7.4 Saudi Arabia Hypersomnia Drug Market Size, 2017-2028
  6.7.5 UAE Hypersomnia Drug Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Teva
  7.1.1 Teva Corporate Summary
  7.1.2 Teva Business Overview
  7.1.3 Teva Hypersomnia Drug Major Product Offerings
  7.1.4 Teva Hypersomnia Drug Revenue in Global Market (2017-2022)
  7.1.5 Teva Key News
7.2 Jazz Pharmaceuticals
  7.2.1 Jazz Pharmaceuticals Corporate Summary
  7.2.2 Jazz Pharmaceuticals Business Overview
  7.2.3 Jazz Pharmaceuticals Hypersomnia Drug Major Product Offerings
  7.2.4 Jazz Pharmaceuticals Hypersomnia Drug Revenue in Global Market (2017-2022)
  7.2.5 Jazz Pharmaceuticals Key News
7.3 BIOPROJET
  7.3.1 BIOPROJET Corporate Summary
  7.3.2 BIOPROJET Business Overview
  7.3.3 BIOPROJET Hypersomnia Drug Major Product Offerings
  7.3.4 BIOPROJET Hypersomnia Drug Revenue in Global Market (2017-2022)
  7.3.5 BIOPROJET Key News
7.4 AVADEL PHARMACEUTICALS
  7.4.1 AVADEL PHARMACEUTICALS Corporate Summary
  7.4.2 AVADEL PHARMACEUTICALS Business Overview
  7.4.3 AVADEL PHARMACEUTICALS Hypersomnia Drug Major Product Offerings
  7.4.4 AVADEL PHARMACEUTICALS Hypersomnia Drug Revenue in Global Market (2017-2022)
  7.4.5 AVADEL PHARMACEUTICALS Key News
7.5 GlaxoSmithKline
  7.5.1 GlaxoSmithKline Corporate Summary
  7.5.2 GlaxoSmithKline Business Overview
  7.5.3 GlaxoSmithKline Hypersomnia Drug Major Product Offerings
  7.5.4 GlaxoSmithKline Hypersomnia Drug Revenue in Global Market (2017-2022)
  7.5.5 GlaxoSmithKline Key News
7.6 Pfizer
  7.6.1 Pfizer Corporate Summary
  7.6.2 Pfizer Business Overview
  7.6.3 Pfizer Hypersomnia Drug Major Product Offerings
  7.6.4 Pfizer Hypersomnia Drug Revenue in Global Market (2017-2022)
  7.6.5 Pfizer Key News
7.7 Theranexus
  7.7.1 Theranexus Corporate Summary
  7.7.2 Theranexus Business Overview
  7.7.3 Theranexus Hypersomnia Drug Major Product Offerings
  7.7.4 Theranexus Hypersomnia Drug Revenue in Global Market (2017-2022)
  7.7.5 Theranexus Key News
7.8 Fisher & Paykel Healthcare
  7.8.1 Fisher & Paykel Healthcare Corporate Summary
  7.8.2 Fisher & Paykel Healthcare Business Overview
  7.8.3 Fisher & Paykel Healthcare Hypersomnia Drug Major Product Offerings
  7.8.4 Fisher & Paykel Healthcare Hypersomnia Drug Revenue in Global Market (2017-2022)
  7.8.5 Fisher & Paykel Healthcare Key News
7.9 Drive Medical
  7.9.1 Drive Medical Corporate Summary
  7.9.2 Drive Medical Business Overview
  7.9.3 Drive Medical Hypersomnia Drug Major Product Offerings
  7.9.4 Drive Medical Hypersomnia Drug Revenue in Global Market (2017-2022)
  7.9.5 Drive Medical Key News
7.10 Merck
  7.10.1 Merck Corporate Summary
  7.10.2 Merck Business Overview
  7.10.3 Merck Hypersomnia Drug Major Product Offerings
  7.10.4 Merck Hypersomnia Drug Revenue in Global Market (2017-2022)
  7.10.5 Merck Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Hypersomnia Drug Market Opportunities & Trends in Global Market
Table 2. Hypersomnia Drug Market Drivers in Global Market
Table 3. Hypersomnia Drug Market Restraints in Global Market
Table 4. Key Players of Hypersomnia Drug in Global Market
Table 5. Top Hypersomnia Drug Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Hypersomnia Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Hypersomnia Drug Revenue Share by Companies, 2017-2022
Table 8. Global Companies Hypersomnia Drug Product Type
Table 9. List of Global Tier 1 Hypersomnia Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hypersomnia Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Hypersomnia Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Hypersomnia Drug Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Hypersomnia Drug Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Hypersomnia Drug Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Hypersomnia Drug Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Hypersomnia Drug Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Hypersomnia Drug Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Hypersomnia Drug Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Hypersomnia Drug Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Hypersomnia Drug Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Hypersomnia Drug Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Hypersomnia Drug Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Hypersomnia Drug Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Hypersomnia Drug Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Hypersomnia Drug Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Hypersomnia Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Hypersomnia Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Hypersomnia Drug Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Hypersomnia Drug Revenue, (US$, Mn), 2023-2028
Table 30. Teva Corporate Summary
Table 31. Teva Hypersomnia Drug Product Offerings
Table 32. Teva Hypersomnia Drug Revenue (US$, Mn), (2017-2022)
Table 33. Jazz Pharmaceuticals Corporate Summary
Table 34. Jazz Pharmaceuticals Hypersomnia Drug Product Offerings
Table 35. Jazz Pharmaceuticals Hypersomnia Drug Revenue (US$, Mn), (2017-2022)
Table 36. BIOPROJET Corporate Summary
Table 37. BIOPROJET Hypersomnia Drug Product Offerings
Table 38. BIOPROJET Hypersomnia Drug Revenue (US$, Mn), (2017-2022)
Table 39. AVADEL PHARMACEUTICALS Corporate Summary
Table 40. AVADEL PHARMACEUTICALS Hypersomnia Drug Product Offerings
Table 41. AVADEL PHARMACEUTICALS Hypersomnia Drug Revenue (US$, Mn), (2017-2022)
Table 42. GlaxoSmithKline Corporate Summary
Table 43. GlaxoSmithKline Hypersomnia Drug Product Offerings
Table 44. GlaxoSmithKline Hypersomnia Drug Revenue (US$, Mn), (2017-2022)
Table 45. Pfizer Corporate Summary
Table 46. Pfizer Hypersomnia Drug Product Offerings
Table 47. Pfizer Hypersomnia Drug Revenue (US$, Mn), (2017-2022)
Table 48. Theranexus Corporate Summary
Table 49. Theranexus Hypersomnia Drug Product Offerings
Table 50. Theranexus Hypersomnia Drug Revenue (US$, Mn), (2017-2022)
Table 51. Fisher & Paykel Healthcare Corporate Summary
Table 52. Fisher & Paykel Healthcare Hypersomnia Drug Product Offerings
Table 53. Fisher & Paykel Healthcare Hypersomnia Drug Revenue (US$, Mn), (2017-2022)
Table 54. Drive Medical Corporate Summary
Table 55. Drive Medical Hypersomnia Drug Product Offerings
Table 56. Drive Medical Hypersomnia Drug Revenue (US$, Mn), (2017-2022)
Table 57. Merck Corporate Summary
Table 58. Merck Hypersomnia Drug Product Offerings
Table 59. Merck Hypersomnia Drug Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Hypersomnia Drug Segment by Type in 2021
Figure 2. Hypersomnia Drug Segment by Application in 2021
Figure 3. Global Hypersomnia Drug Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Hypersomnia Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Hypersomnia Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Hypersomnia Drug Revenue in 2021
Figure 8. By Type - Global Hypersomnia Drug Revenue Market Share, 2017-2028
Figure 9. By Application - Global Hypersomnia Drug Revenue Market Share, 2017-2028
Figure 10. By Region - Global Hypersomnia Drug Revenue Market Share, 2017-2028
Figure 11. By Country - North America Hypersomnia Drug Revenue Market Share, 2017-2028
Figure 12. US Hypersomnia Drug Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Hypersomnia Drug Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Hypersomnia Drug Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Hypersomnia Drug Revenue Market Share, 2017-2028
Figure 16. Germany Hypersomnia Drug Revenue, (US$, Mn), 2017-2028
Figure 17. France Hypersomnia Drug Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Hypersomnia Drug Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Hypersomnia Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Hypersomnia Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Hypersomnia Drug Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Hypersomnia Drug Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Hypersomnia Drug Revenue Market Share, 2017-2028
Figure 24. China Hypersomnia Drug Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Hypersomnia Drug Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Hypersomnia Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Hypersomnia Drug Revenue, (US$, Mn), 2017-2028
Figure 28. India Hypersomnia Drug Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Hypersomnia Drug Revenue Market Share, 2017-2028
Figure 30. Brazil Hypersomnia Drug Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Hypersomnia Drug Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Hypersomnia Drug Revenue Market Share, 2017-2028
Figure 33. Turkey Hypersomnia Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Hypersomnia Drug Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Hypersomnia Drug Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Hypersomnia Drug Revenue, (US$, Mn), 2017-2028
Figure 37. Teva Hypersomnia Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Jazz Pharmaceuticals Hypersomnia Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. BIOPROJET Hypersomnia Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. AVADEL PHARMACEUTICALS Hypersomnia Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. GlaxoSmithKline Hypersomnia Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Pfizer Hypersomnia Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Theranexus Hypersomnia Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Fisher & Paykel Healthcare Hypersomnia Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Drive Medical Hypersomnia Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Merck Hypersomnia Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)